The recently published market research report titled Global Nanotechnology in Cancer Treatment Market Growth (Status and Outlook) 2020-2025 monitors the demand-side and supply-side trends. The report provides in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities. It looks over the market into various segments, end-users, regions, and players on the basis of demand patterns, and prospect for 2020 to 2025 time-period. The various affecting factors like market share, competitive intelligence, and growth opportunity are elaborated in the report.

Understanding The Competitive Scenario:

Competitive landscape analysis contains major players analysis with their company profiles cover the product offerings, key financial information, recent developments, SWOT analysis, capacity, production, price, revenue, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, and strategies employed by them. This report offers in-depth information about the major market players in the global Nanotechnology in Cancer Treatment market: Merck, Smith & Nephew, Ferro, Capsulution Nanoscience, AstraZeneca, AMAG Pharmaceuticals, Stryker Corporation, Affymetrix, Starkey Hearing Technologie, PerkinElmer, St. Jude Medica, Acusphere

DOWNLOAD FREE SAMPLE REPORT: https://www.marketandresearch.biz/sample-request/122232

Regional Growth Analysis:

All major regions and countries have been covered in the Nanotechnology in Cancer Treatment report. The regional analysis will help market players to tap into unexplored regional markets, prepare specific strategies for target regions, and compare the growth of all regional markets. In addition, a study related to the market concentration rate as well as the concentration ratio over the estimated time period is presented. Based on the region, the global market has been segmented into: Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries)

As per the product type, the market is categorized into: Nanostructured Materials, Nanotools, Nanodevices, Other

According to the application spectrum, the market is categorized into: Hospital, Laboratory, Others

The report highlights a detailed investigation of the global Nanotechnology in Cancer Treatment market chain structure, downstream buyers, market positioning, upstream raw material data, and different industrial strategies. Data associated with the latest trends driving the market along with the challenges this industry is about to experience in the upcoming years is mentioned in the report. SWOT analysis is also incorporated in the report along with venture return investigation. The study incorporates others such as economic scenarios, benefits, limits, trends, market growth rates, and figures.

ACCESS FULL REPORT: https://www.marketandresearch.biz/report/122232/global-nanotechnology-in-cancer-treatment-market-growth-status-and-outlook-2020-2025

Implementing Marketing Tactics:

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketandresearch.bizWeb: http://www.marketandresearch.biz

Link:

Global Nanotechnology in Cancer Treatment Market 2020 Industry Size, Shares and Upcoming Trends 2025 - Sask News Now

VANCOUVER, British Columbia, March 31, 2020 /PRNewswire/ --Executives of NTI Nanotechnology Corp. ("NTI"), headquartered in British Columbia, Canada, made a bold claim today as they released information on a suite of anti-bacterial and anti-viral products. The products were initially scheduled to launch in Q3 and Q4 of 2020. Given the current COVID-19 supply chain issues governments are experiencing for medical grade sanitizers, and PPE, the company has accelerated its timeline for the release of its anti-viral YZER Health Product line.

The public can now get a glimpse of the important role nanotechnology is playing for a sustainable future of the planet and people.

The YZER suite of products provide solutions ranging from anti-bacterial and anti-viral applications in a variety of substrates, including Textiles, Plastics and Sanitizers (branded as YZER Health). Additionally, large scale construction products (branded as YZER Infrastructure) through ecological mitigation (YZER Environment) are available to provide sustainable solutions in what has typically been industries that can leave behind unmitigated environmental damage.

While the first products were due to be launched in the summer, the company is now working alongside the Canadian Trade Commissioner Service and Export Canada launching in to global markets and providing solutions for the destructive COVID-19 global pandemic.

"We will be accelerating the logistics to supply the market with premium grade hand sanitizer and face masks that have proven general anti-viral properties because of a unique formulation of state-of-the-art Silver Nano Particles. Additionally, we are accelerating manufacturing surface wipes and products like face masks and gowns that have anti-viral properties. We would hope to be in the market a few months ahead of the original forecast," said CEO of NTI, Andre Voskuil, adding, "Clearly the problem that we are experiencing today is with a medical industry that has had no option but to dispose frequently of their clothing and PPE. The application of Nanotechnology will allow us to provide reusable PPE and clothing reducing the burden on the supply chain."

The company is in discussions with manufacturers and packaging companies in North America to assist with distribution of their product lines and is looking to expand its local network of companies, which can process NTI's proprietary nanotechnology material.

The YZER brand of products is powered by cutting-edge nanotechnology that was scientifically developed in Argentina and is currently manufactured there. NTI and their Argentinian partners are one of few companies world-wide, which have developed and proven Nanotechnology products on an industrial scale. The Yzer Health products utilize Nano Colloidal Silver, which has long been known to have strong anti-microbial and anti-bacterial properties. This effect is then amplified tremendously through the application on the Nano-scales. As research also has shown anti-viral properties that could be very important in preventing the spread of pandemics such as COVID-19.

"Frankly, we wanted to plan an orderly and systematic path to market, but given the current global challenges, we felt it was incumbent on us to release the products as quickly as possible. We are getting support from our Canadian Trade Commissioner Service to seek partners for both local production and distribution for both our already existing and newly developed products," added Voskuil.

NTI's COO, Robert Schwetzke and his team, are working with various government agencies to coordinate manufacturing, bottling and distribution of the products from bases in Europe and North America. "The good news for us is that the Argentinian government had already certified the products asmedical gradesafe for use and that, with some good fortune will reduce the complexity of getting to market in a short period of time," said Schwetzke. "It is, however, important to partner with local manufacturers."

For more information on the suite of Nanotechnology products, visit http://www.YZERFuture.com

Contact:[emailprotected]+1 250 859 4893

About YZER FUTURE

Yzer Future is a brand centered on ESG principles that progress and commerce do not come at the sacrifice of a community or environment.

The fundamental Vision of the team at Yzer Future are to identify disruptive solutions to old problems that have resisted change. As such the company has isolated Nano-technologies that have been pioneered, researched and proven at labs and universities around the world and are ready to be applied on an economically viable industrial scale.

About Nanotechnology applied by NTI

The science of the manipulation of materials on the nano-scale has been around since the 1980's. As chemical and physical properties of material often change greatly at this scale, specific nanoparticles can be created, which deploy certain behaviors on the molecular level.

All of NTI's Nanoparticles are made of either Silver, Iron or Zinc, and only organic reducers are used in the manufacturing process, making them safe to use.

The Yzer Health products utilize Colloidal Nano-Silver particles in the size range <50nm and have proven to interact extremely efficiently bacteria and viruses.

SOURCE Yzer Future

View post:

Nanotechnology May Have The Solution For Virus Transmission Reduction - PRNewswire

March 30, 2020

A new approach to stopping virus growth gives hope for new therapeutic options against seasonal influenza, bird flu and possibly COVID-19, says Dr. Ned Budisa, Tier 1 Canada Research Chair in Chemical Synthetic Biology at UM and who holds an adjunct position at the Technical University in Berlin.

Budisa is a member of an international partnership led by German researchers that has developed a chemically engineered nanoparticle that literally takes the air to breathe away from influenza viruses. The team has found these nanoparticles are biodegradable, non-toxic, and not immunogenic in cell culture studies.

Budisa and other Manitoba researchers are working with researchers from the Leibniz Research Institute for Molecular Pharmacology (FMP), the Free University of Berlin (FU), the Humboldt University (HU), the Robert Koch Institute (RKI), and the Charit. This multidisciplinary team of researchers has succeeded to envelop flu viruses in a nanoparticle scaffold so that they cannot infect their host cells. This promising result has just been published in the scientific journal Nature Nanotechnology.

Budisa says the key to the discovery of the new influenza inhibitor was the collaboration of scientists from many disciplines including biologists, chemists, physicists, virologists, physicians, and imaging. Budisas team produced and engineered nanoparticles with synthetic biology that were then chemically modified by other team members. High-resolution electron microscopy and tomography images impressively show that the inhibitor completely encapsulates the virus. The team has even demonstrated this applications therapeutic potential in human lung tissue; if tissue infected with flu viruses was treated with the synthetic phage capsid the part of the virus that contains its genetic material the influenza viruses could no longer multiply.

Budisa notes: Further preclinical examinations must now follow, since it is not yet known whether the phage capsid provokes an immune response in mammals or whether repeated administration would lead to development of resistance towards flu viruses.

He cautions: There is still no proof that the inhibitor is also effective in humans. Therefore, therapeutic potential needs to be researched further.

Influenza viruses are still extremely dangerous. According to estimates by the World Health Organization (WHO), up to 650,000 people worldwide die from the flu every year.

Budisa says: Existing antiviral drugs are only partially effective because they only attack the flu virus when it has already infected the lung cells. It would be desirable and far more effective to prevent the infection from the outset.

Chris Rutkowski

Follow this link:

International collaboration developing nanotechnology that may be used against COVID-19 - UM Today

(MENAFN - Grand Research Store) This report focuses on the global Cell Dissociation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Dissociation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-cell-dissociation-2020-2026-851

BDRocheThermo Fischer ScientificPan-BiotechStemcell TechnologiesGE HealthcareHimedia LaboratoriesMerckMiltenyi BiotecREPROCELLALSTEMCellSystems Biotechnologie VertriebBiological IndustriesPelobiotechBrainBitsLabochemaPromoCellBio-TechneBiocompareGemini Bio-Products

Market segment by Type, the product can be split into

Enzymatic Dissociation ProductsNon-Enzymatic Dissociation ProductsInstruments & Accessories

Market segment by Application, split into

Antibody ProductionVeterinary ApplicationsCell Culture MaintenanceImmunoassaysOthers

Market segment by Regions/Countries, this report covers

North AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

The study objectives of this report are:

To analyze global Cell Dissociation status, future forecast, growth opportunity, key market and key players.To present the Cell Dissociation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cell Dissociation are as follows:

History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-cell-dissociation-2020-2026-851

Table of content

Table of Contents

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered: Ranking by Cell Dissociation Revenue1.4 Market Analysis by Type1.4.1 Global Cell Dissociation Market Size Growth Rate by Type: 2020 VS 20261.4.2 Enzymatic Dissociation Products1.4.3 Non-Enzymatic Dissociation Products1.4.4 Instruments & Accessories1.5 Market by Application1.5.1 Global Cell Dissociation Market Share by Application: 2020 VS 20261.5.2 Antibody Production1.5.3 Veterinary Applications1.5.4 Cell Culture Maintenance1.5.5 Immunoassays1.5.6 Others1.6 Study Objectives1.7 Years Considered

2 Global Growth Trends by Regions2.1 Cell Dissociation Market Perspective (2015-2026)2.2 Cell Dissociation Growth Trends by Regions2.2.1 Cell Dissociation Market Size by Regions: 2015 VS 2020 VS 20262.2.2 Cell Dissociation Historic Market Share by Regions (2015-2020)2.2.3 Cell Dissociation Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy2.3.1 Market Top Trends2.3.2 Market Drivers2.3.3 Market Challenges2.3.4 Porter?s Five Forces Analysis2.3.5 Cell Dissociation Market Growth Strategy2.3.6 Primary Interviews with Key Cell Dissociation Players (Opinion Leaders)

3 Competition Landscape by Key Players3.1 Global Top Cell Dissociatio

CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email:

Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/

MENAFN01042020007010732ID1099947421

Visit link:

Healthcare Nanotechnology Market Size, Status and Forecast 2020-2026 - MENAFN.COM

Company Completes Necessary FDA Notifications to Assist in Fight Against COVID-19

HOUSTON, April 02, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc.(the Company or C-Bond) (CBNT), a nanotechnology solutions company, today announced it has temporarily converted its manufacturing facility to produce hand sanitizer for both healthcare professionals and consumers to assist in the fight against COVID-19.

The Company will produce C-Bond Antiseptic Hand Rub, a professional grade World Health Organization (WHO) hand sanitizer formula to fulfill bulk orders received from healthcare customers at its Houston-based manufacturing facility. All necessary FDA notifications are complete for production to proceed.

In this unprecedented time of need, it is imperative that we all do our part to help combat the spread of COVID-19, said Scott R. Silverman, Chairman and Chief Executive Officer of C-Bond. Therefore, we are dedicating a portion of our facility to the production of hand sanitizer to provide much needed supplies to healthcare professionals on the front lines. This represents a unique revenue opportunity for C-Bond and allows us to most efficiently leverage our manufacturing infrastructure.

For consumers or companies interested in placing a bulk order for hand sanitizer, please contact the C-Bond Systems corporate office at (832) 649-5658.

About C-Bond C-Bond Systems, Inc. (CBNT) is a Houston-based advanced nanotechnology company and marketer of the patented C-Bond technology, developed in conjunction with Rice University and independently proven to significantly strengthen glass in key automotive and structural applications. The Companys Transportation Solutions Group sells C-Bond NanoShield, a liquid solution applied directly to automotive windshields, sold through distributors. The Companys Safety Solutions Group sells ballistic-resistant glass solutions directly to private enterprises, schools and government agencies. For more information, please visit our website atwww.cbondsystems.com, Facebook: https://www.facebook.com/cbondsys/ and Twitter: https://twitter.com/CBond_Systems.

Story continues

Forward-Looking StatementsStatements in this press release about our future expectations, including the likelihood that we will produce C-Bond Antiseptic Hand Rub, a professional grade WHO hand sanitizer formula to fulfill bulk orders received from healthcare customers; the likelihood that this represents a unique revenue opportunity for C-Bond and allows us to most efficiently leverage our manufacturing infrastructure; constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and our actual results could differ materially from expected results. These risks and uncertainties include, without limitation, C-Bonds ability to raise capital; the Companys ability to successfully commercialize its products; the Companys ability to operate during the COVID-19 pandemic; as well as other risks. Additional information about these and other factors may be described in the Companys filings with the Securities and Exchange Commission (SEC) including its Form 10-K filed on March 25, 2020, its Forms 10-Q filed on November 14, 2019, August 12, 2019, and May 10, 2019, and in future filings with the SEC. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Investor Contacts:

Luke ZimmermanVice PresidentMZ Group - MZ North America949-259-4987CBNT@mzgroup.uswww.mzgroup.us

Allison TomekVP, Corporate CommunicationsC-Bond Systems, Inc.atomek@cbondsystems.com832-649-5658

Read more:

C-Bond Systems Temporarily Converts Manufacturing Facility to Produce Hand Sanitizer - Yahoo Finance

THOMS Aviation and Automotive Products include Antibacterial and Antiviral Protection for Covid-19 and Other Pathogens

THOMS Current Customers Include Transavia, KLM Cityhopper and EasyJet

HOUSTON, March 30, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc.(the Company or C-Bond) (OTC: CBNT), a nanotechnology solutions company , today announced it has entered into joint marketing and distribution agreements with THOMS Aviation, THOMS Automotive, and EXEGi Trading Company (based in the Netherlands) to expand its nano products portfolio and form a reciprocal nanotechnology product supply and distribution network in the transportation industry in key markets. The agreement provides a mutual option for the companies to invest in the other for up to 20% ownership.

Per the terms of the agreement, C-Bond will become a distributor of THOMS and EXEGis suite of complementary nanotechnology products for planes, trains and automobiles. Among other products, C-Bond will distribute THOMSs Virus Protection cleaner, a nanotechnology-based chemical treatment that cleans and disinfects interior surfaces for a minimum of 7 days. THOMS has used this product with multiple major airlines in the European Union like Transavia, EasyJet, Corendon Dutch Airlines and KLM Cityhopper, and it is a key tool in the fight against the spread of pathogens such as COVID-19.

C-Bond will also have the ability to market THOMS Automotive and EXEGi Trading products, which include interior and exterior cleaning and performance products, to its transportation customers in the U.S. Additionally, THOMS Aviation, THOMS Automotive and EXEGi Trading Company will distribute C-Bond products in the European Union.

THOMS and EXEGi have developed a superior nanotechnology cleaning solution to sanitize and disinfect against Covid-19 and other pathogens, and have collectively built a comprehensive global distribution network. We believe they are an ideal niche partner to help us grow our nanotechnology product portfolio, said Scott R. Silverman, Chairman and Chief Executive Officer of C-Bond. This strategic partnership represents an incredible opportunity to cross-sell products from our increasingly robust product suite into a diverse global client base, with the unique option of taking an equity stake in our partner if we deem appropriate. Together, our companies have the potential to create significant long-term shareholder value while addressing key global headwinds such as COVID-19.

We are excited to partner with a thought leader like C-Bond Systems to provide our protective product expertise and distribution network to complement their impressive product line and network, said Thomas de Boer, Chief Executive Officer of THOMS Aviation and Raymond Donker, Managing Director of THOMS Automotive. C-Bond is one of the industry's leading names in nanotechnology solutions and we look forward to working closely with the management team at C-Bond as we jointly scale operations globally.

About THOMS AviationTHOMS Aviation company offers Aviation Services which comprise of Aircraft Exterior Cleaning and Interior Deep Cleaning in Schiphol, Rotterdam and Eindhoven airports, but also started Q4 2019 in Berlin at Tegel and Schonefeld airports. THOMS Aviation is committed to minimizing the environmental impact of its operations through the adoption of sustainable practices and continual improvement in environmental performance. We accept the 'Duty of Care' imposed by legislation as the minimum standard to be set and maintained, and we aim to develop a sustainable business that is financially viable, environmentally sustainable, and socially equitable. For more information please visit http://www.thoms-aviation.com.

About THOMS AutomotiveTHOMS Automotive provides services primarily for business users like fleet owners, fleet keepers, and government organizations on location. At THOMS Automotive we work ecologically responsibly. On an average bass we save about 250 liters of drinking water per car by using our Dry Wash procedure as compared to the traditional car wash services.For more information please visit http://www.thoms-automotive.com.

About EXEGi Trading Company Dutch-based EXEGi Trading Company is the sole producer and dealer of THOMS and C-Bond products. Some of its core businesses are cleaning, enhancement and protection products. EXEGi partners with Chrisal, https://www.chrisal.com/#/, to provide leading-edge probiotic disinfecting materials.

About C-Bond C-Bond Systems, Inc. (OTC: CBNT) is a Houston-based advanced nanotechnology company and marketer of the patented C-Bond technology, developed in conjunction with Rice University and independently proven to significantly strengthen glass in key automotive and structural applications. The Companys Transportation Solutions Group sells C-Bond NanoShield, a liquid solution applied directly to automotive windshields, sold through distributors. The Companys Safety Solutions Group sells ballistic-resistant glass solutions directly to private enterprises, schools and government agencies. For more information, please visit our website atwww.cbondsystems.com.

Forward-Looking Statements

Statements in this press release about our future expectations, including the likelihood that C-Bond Systems will become a distributor of THOMS and EXEGis suite of complementary nanotechnology products for planes, trains and automobiles; the likelihood that C-Bond will distribute THOMSs Virus Protection cleaner, a nanotechnology-based chemical treatment that cleans and disinfects interior surfaces for a minimum of 7 days; the likelihood that C-Bond will also have the ability to market THOMS Automotive and EXEGi Trading products, which include interior and exterior cleaning and performance products, to its transportation customers in the U.S.; the likelihood that THOMS Aviation, THOMS Automotive and EXEGi Trading Company will distribute C-Bond products in the European Union; the likelihood that our companies have the potential to create significant long-term shareholder value while addressing key global headwinds such as COVID-19; constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and our actual results could differ materially from expected results. These risks and uncertainties include, without limitation, C-Bonds ability to raise capital; the Companys ability to successfully commercialize its products; as well as other risks. Additional information about these and other factors may be described in the Companys filings with the Securities and Exchange Commission (SEC) including its Form 10-K filed on March 25, 2020, its Forms 10-Q filed on November 14, 2019, August 12, 2019, and May 10, 2019, and in future filings with the SEC. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

More:

C-Bond Systems Partners with THOMS Aviation, THOMS Automotive, and EXEGi Trading Company in Joint Marketing and Distribution Agreements to Expand its...

The Nanotechnology in Drug Delivery market report [5 Years Forecast 2020-2025] focuses on Major Leading Industry Players, providing info like market competitive situation, product scope, market overview, opportunities, driving force and market risks. Profile the top manufacturers of Nanotechnology in Drug Delivery, with sales, revenue and global market share of Nanotechnology in Drug Delivery are analyzed emphatically by landscape contrast and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is additionally administrated. The Nanotechnology in Drug Delivery market business development trends and selling channels square measure analyzed. From a global perspective, It also represents overall industry size by analyzing qualitative insights and historical data.

The study encompasses profiles of major companies operating in the global Nanotechnology in Drug Delivery market. Key players profiled in the report includes : Access PharmaceuticalsAlkermesAquanovaCamurusCapsulution PharmaCelgene and among others.

Get Free Sample PDF (including full TOC, Tables and Figures) of Nanotechnology in Drug Delivery Market @https://www.researchmoz.us/enquiry.php?type=S&repid2303549

This Nanotechnology in Drug Delivery market report provides a comprehensive analysis of:Industry overview, cost structure analysis, technical data and competitive analysis, topmost players analysis, development trend analysis, overall market overview, regional market analysis, consumers analysis and marketing type analysis.

Scope of Nanotechnology in Drug Delivery Market:

The global Nanotechnology in Drug Delivery market is valued at million US$ in 2019 and will reach million US$ by the end of 2025, growing at a CAGR of during 2020-2025. The objectives of this study are to define, segment, and project the size of the Nanotechnology in Drug Delivery market based on company, product type, application and key regions.

This report studies the global market size of Nanotechnology in Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nanotechnology in Drug Delivery in these regions.

This research report categorizes the global Nanotechnology in Drug Delivery market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors, customers, research findings & conclusion, appendix & data source and Porters Five Forces Analysis.

The end users/applications and product categories analysis:

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate foreach application.

On the basis of product,this report displays the sales volume, revenue (Million USD), product price, market share and growth rate ofeach type.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid2303549

(*Fill the form and our sales representative will get back to you for assistance)

Nanotechnology in Drug Delivery Market The Regional analysis covers:

Key Takeaways and Reasons To Buy Nanotechnology in Drug Delivery Market Report:

And Many More.Contact Us:

ResearchMozMr. Nachiket Ghumare,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email: [emailprotected]Follow us on LinkedIn @ http://bit.ly/2RtaFUo

Follow me on : https://marketnews-24.blogspot.com/

Go here to see the original:

Nanotechnology in Drug Delivery Market Research By Growth, Competitive Methods And Forecast To 2025 - The Fuel Fox

Nanotechnology is able to unlock thousands of hectares of land previously restricted for wind farm construction, increasing the potential for green power generation globally. A recently developed graphene nanotube-modified polymer is a game-changing technology that solves a great challenge of the renewable energy industry wind farm radar interference.Wind power's share in worldwide electricity generation is increasing, helping to drastically decrease CO2 emissions. But along with undeniable advantages, wind energy has a serious problem. Wind turbines can cause interference to radar and other navigation systems, making it difficult for air-traffic controllers to track aircraft through the "clutter". This problem causes a large number of prohibitions on constructing wind farms in areas with intensive air traffic. In some countries, more than 60% of the entire territory is restricted for wind farms construction, blocking gigawatts of potential renewable energy capacity.Developers from British company Trelleborg Applied Technology, which specializes in engineered material solutions, has found a way to solve this issue using graphene nanotubes (also known as single wall carbon nanotubes). We realize that the problem is the large radar cross section of the turbine, so if we can reduce this, we remove the clutter and solve radar interference, Dr Adam Nevin, Innovation Lead of Trelleborg Applied Technologies, explains. In order to reduce it, we are using single wall carbon nanotubes and making nanocomposite which absorbs over 99% of the incident radar wave to make the coated object stealthy, which makes it much easier to track aircraft and observe storms.Along with nanotubes' ability to efficiently absorb waves, they also allow new material to be extremely thin. The developers emphasize that this material would otherwise be many centimeters thick, but they managed to reduce it down to just millimeters, thus obtaining an ultra-lightweight nanopolymer. The new absorbing material uses graphene nanotubes, produced by OCSiAl.

As Dr Adam Nevin said, the product went through a full development cycle from initial research to a scaled-up solution within only 10 months only. The new absorbing material can be used in diverse product applications in telecommunications, automotive, electronic and antennae solutions, where strict regulations on electromagnetic interference and stray radio-frequency emissions apply.

See more here:

Graphene nanotubes can increase the number of wind turbines to decrease CO2 emissions - Engineer Live

By Louis Fourie Mar 20, 2020

Share this article:

One of the fastest-growing nanotechnology fields is biomedicine, where the sheer number and range of innovations makes it hard to stay abreast of the newest developments.

Many of these breakthroughs made over the past few months could significantly change the quality of peoples lives in the future. Scientists from Michigan State University and Stanford University in the US have invented a nanoparticle that removes the plaque that causes heart attacks.

In the Nature Nanotechnology of January 27, associate professor Brian Smith and a team of scientists published an article that describes how they created a Trojan Horse nanoparticle that can be guided to eat debris, reducing and stabilising plaque.

This discovery is an important breakthrough in the potential treatment for atherosclerosis, which is one of the leading causes of heart disease, stroke and death in South Africa.

The nanoparticle has a high selectivity for macrophages (a cell responsible for detecting and destroying germs) and once inside the macrophages in the plaques, it delivers a drug agent that stimulates the cell to surround and devour dead and dying cells.

The macrophage-specific nanotherapy removes the dead cells in the core of the plaque. By reviving the macrophages through the delivery of nanoparticle messages, the plaque size is decreased and stabilised, and the risk of heart attacks reduced.

Scientists at Rice University, Biola University and Texas A&M Health Science Center (US) developed nanodrills to treat skin diseases. The light-activated molecular nanomachines, originally designed to target drug-resistant bacteria, cancer and other disease-causing cells by drilling holes into their cell walls, are now able to kill whole eukaryotic organisms (whose cells have a nucleus such as animals).

Customised nanomachines with spatial and temporal control that target specific tissues for therapy could also be used in a variety of benign and malignant disease states, among others the treatment of cancer, parasites, bacteria and diseased tissues. It could also help to fight drug-resistant pneumonia where antibiotics have proven ineffective, as well as be used for environmental parasite control.

On December 17 a group of researchers from Chalmers University of Technology in Sweden published an article in the highly regarded scientific journal ACS Nano, where they explain their creation of a new, nanostructured rubber-like material with a unique set of properties that could replace human tissue in medical procedures.

This mesoporous (a material containing pores with diameters between 2 and 50 nanometres) elastomer (a polymer with elastic properties) could make a huge difference to many peoples lives in the future.

The nanorubber is soft, flexible, extremely elastic, can easily be processed and is, therefore, very suitable for medical use. What makes it so valuable is that the material can be constructed to prevent bacteria to grow on the surface through placing antimicrobial peptides (small proteins, which are part of our innate immune system) on it. This could help reduce the need for antibiotics and thus help in the fight against increasing antibiotic resistance.

Without doubt, the nanoworld of atoms and molecules - where everything is measured in nanometres, or a billionth of a metre - has many more secrets, new materials and incredible innovations to offer that will certainly change our future.

Professor Louis C H Fourie is a futurist and technology strategist. [emailprotected] For the full version of this article, go to http://www.busrep.co.za

BUSINESS REPORT

Read more:

Tech News: Nanotechnology at the centre of big innovations - IOL

Personnel from the Air Force Research Laboratory joined dozens of industry and military partners at Northern Arizona University Feb. 25, 2020, to discuss a multimillion-dollar cybersecurity project headed by Professor Bertrand Cambou.

Cambou, a professor of nanotechnology and cybersecurity in the School of Informatics, Computing, and Cyber Systems, is the principal investigator on a grant from the U.S. Air Force to develop nanotechnology solutions to cyberattacks and cyber warfare. SICCS professor Paul Flikkema is the PI on a grant aimed at developing hardware for computer diversity. Together, the grants total $6.3 million and include a dozen researchers and students at NAU.

Because of the complexity and constantly changing nature of cybersecurity and computing diversity issues, the Department of Defense brought in additional partners to aid in the transfer of technologies, which is always a huge task. That group met at NAU to seek clarity on the critical tasks and objectives of the work.

Not only are these complicated issues, but the work of about 12 faculty members at NAU has to be coordinated with seven different organizations, Cambou said. Therefore, we are implementing a process to drive the program management of the entire program.

Partners from the Air Force Research Labs Information Directorate, Space Vehicles Directorate and Materials and Manufacturing Directorate; the Office of Naval Research; Sandia National Laboratory; Lockheed Martin; and Crossbar Inc. are part of this project, which has two major goals:

Hackers and cyber-criminals continuously probe and attack legacy infrastructure that was not designed to combat the ever-evolving complex assaults, Telesca said. With the existing infrastructure continuing to be weak to cyberattacks, it is time to consider radical architectural and infrastructural changes intended to disrupt the status quo and support a healthier cybersecurity ecosystem through computational diversity.

We are excited and honored that AFRL recognizes our facultys innovative approach in identifying nontraditional solutions to the increasing danger of cyberattacks and cyber warfare, NAU President Rita Cheng said as she welcomed the group. The impact of this work reaches all corners of modern life, helping to protect factories, power plants, transportation systems, drones, personal medical devices and much more.

The Air Force Research Laboratory is the primary scientific research and development center for the Air Force. AFRL plays an integral role in leading the discovery, development, and integration of affordable warfighting technologies for our air, space, and cyberspace force. With a workforce of more than 11,000 across nine technology areas and 40 other operations across the globe, AFRL provides a diverse portfolio of science and technology ranging from fundamental to advanced research and technology development.

The rest is here:

AFRL partners with Northern Arizona University, DOD labs, industry to develop nanotechnology solutions to cyberattacks and cyber warfare - Aerotech...

Name: Drew Ely

Residence: North Canton

Age: 18

School: GlenOak High School

GPA: 4.714

College choice: Undecided

Parents: Anne and Chris Ely

Describe yourself in three words: Curious, Funny, Driven

School activities: Cross country, track, Academic Challenge, Ohio Model United Nations, National Honors Society

Community Activities: National Honors Society, women's health drive, race volunteering

Honors and Awards: ACT score of 35, 2 Academic Letters, 4 Cross Country Letters, 3 Track Letters, 3 Debate Letters, Public Forum Debate State Qualifier

Nominated By: Jennifer Austin, international baccalaureate diploma programme English language and literature teacher and Emily Palmer, international baccalaureate diploma programme director coordinator and theory of knowledge teacher.

What is your favorite thing to do outside school: To play games with my friends. A few years ago, a friend of mine introduced me to Dungeons and Dragons, and I've been hooked ever since.

Favorite High School Memory: My first cross country practice in the rain. Heavy rain during cross country always seems to make practice more fun and less painful, and a mixture of bad singing, running through miniature lakes and rivers of water, and yelling in joy made that day extremely enjoyable.

Most people would be surprised to know. . .: I have a girlfriend.

What do you hope to do as a career: I hope to become a biomedical engineer with a specialization in nanotechnology. I plan on utilizing nanotechnology to prevent and alleviate prevalent illnesses and issues.

What is the biggest issue facing teens today?: The wasting of potential. Teenagers often feel discredited and ignored, yet remain ignorant to important information, disrespectful, and undedicated to bettering themselves as people. The reason I believe this is such a large issue is because many teens have the ability to achieve greatness, but settle for complacency. There is an opportunity inherent within this generation to create positive change in the world, and we have a responsibility to fulfill that potential.

Boys

Alliance High School

DeSean Hollins

Nominated by: Carrie Chunat, vocal music teacher and Christian Shively, teacher

Canton South High School

Logan Phillip Bergert

Nominated by: Cathy Ferrell, English teacher

Central Catholic High School

Justin Matthew Buckland

Nominated by: Penny Harris, AP English teacher and Jeff Lindesmith, guidance officer

East Canton High School

Demetrius Snellenberger

Nominated by: Kelly Lenhart and Tom Loy

Hoover High School

Jaideep Ram Seth

Nominated by: Tiffany Walker, AP junior English teacher and Dave Birtcher, AP US history teacher

Jackson High School

Alexander John Regas

Nominated by: Julie Prato, school counselor and Kevin Walsh, teacher

Lake Center Christian School

Blake Sommers

Nominated by: Sharon Martin, English teacher, advanced placement instructor, National Honor Society advisor and Malone University English adjunct professor and Jennings Bryan Luton Jr., math and history teacher

Lake High School

Janson Smith

Nominated by: Zachary McCoy, economics teacher and Aja Tompot, marketing and business management teacher

Louisville High School

Hunter Michael Vaught

Nominated by: Jen Schaeffer, English teacher and Mike McKinney, science teacher

Marlington High School

Daniel Greco

Nominated by: Sam Alhadid, chorus teacher and Matthew Denny, robotics teacher

McKinley High School

Trenton Eaves

Nominated by: Lori Nickels, head of counselors and Manuel Halkias, teacher and director of speech

Minerva High School

Luke Craddock

Nominated by: Lisa Kuehn, honors mathematics teacher, National Honors Society advisor, Top 10 Percent coordinator, honors night coordinator and winter homecoming advisor and Brett Yeagley, principal

Perry High School

Nickolas Baret Forchione

Nominated by: Kevin McDougal, social studies teacher and speech and debate coach and Christopher Meiser, social studies department head

Sandy Valley High School

Nash English Monroe

Nominated by: Lori Ann Trachsel, media specialist and student council advisor and Michelle Crowe, business and English teacher

Tuslaw High School

Bradley Daniel Goff

Nominated by: Sharon Fannin, English teacher and Neil Parrot, science teacher

Originally posted here:

Drew Ely of GlenOak, Malone University Teen of the Month - Canton Repository

A sequence of advancements in materials and design has allowed producers to work at scales smaller than a billionth of a meter. At these sizes,it is attainable to create units and objects that sometimes arent attainable and to manufacture supplies that behave in a different way on account of their dimensions.

These supplies and applied sciences known as nanotechnology provide a spread of advantages forproducers. Regardless of the novelty of the know-how, theyre already being utilized in mass manufacturing.

Beneath, well break down what nanotechnology is and the way the brand new know-how is related to manufacturing.

Nanotechnology is the manufacture and manipulation of nanoscopic supplies and know-how. As a result of the sector has solely come into large use in manufacturing just lately, there are competing definitions for what counts as nano. One well-liked definition for nanomaterials, which make up the majority of nanotechnology at present in use, was set by the European Fee. It defines nano as any materials made up of at the least 50% of particles betweenone and 100 nanometers in size or, about one-hundredth to one-tenth the scale of the typical germ.

This definition consists of each manufactured and naturally occurring nanomaterials, like volcanic ash.

Nanotechnology has grown quickly over the previous few years. There are a number of causes for the sudden development, together with the sensible. Working at microscopic scales permits you to, for instance, create ultra-thin and versatile circuit boards. Plus, there are distinctive benefits that solely nanomaterials can provide.

These tiny suppliestypicallybehave in a different way than normal supplies and have distinctive or uncommon properties on account of their construction. For instance, there are carbon nanotubes, that are a few of the best-known nanomaterials. These nanotubesare extremely sturdy and light-weight, have a near-limit tip-surface space, are extremely chemically secure and are extra thermally conductive than diamond.

Along with these nanoscale supplies, nanotechnology additionally consists of domains like nanomedicine, nanoelectronics and nanorobotics. These are subdomains of bigger fields which might be working on nanoscale.Outdoors of nanomaterials, nanorobotics and nanoelectronics are probably essentially the most related to manufacturing.

There are two broad classes of strategy to nanofabrication, themanufacturing of nanomaterials: top-down and bottom-up.

With a top-down manufacturing strategy, a producer will begin with bigger supplies and use chemical and bodily processes to interrupt them down into nanoscopic components. This strategy is usually employed when a producer wants to use a fabric that is available at regular scales on the nano stage. For instance, diamonds have naturally excessive thermal conductivity. Diamond nanoparticles present comparable properties, however can be utilized in several methods or blended into liquids like mineral oil.

Backside-up manufacturing begins with particular person molecules or compounds and makes use of a mix of chemical and bodily processes to hitch them collectively into nanoscopic supplies. Many nanomaterials which have distinctive or uncommon constructions like carbon nanotubes are manufactured with a bottom-up strategy.

As a result of theres such a spread of various nanomaterials, theres additionally all kinds of potential purposes.

Carbon nanotubes are a few of the most generally used nanomaterials, merely as a result of materialss set of distinctive traits. Theyre already being utilized in conditions the place a producer wants excessive put on resistance and break power at a light-weight weight for instance, bike frames, bulletproof vests, industrial robotic arms, sailboat hulls and spaceship parts, amongst others.

The distinctive construction of those nanotubes additionally makes them efficient in water purification and drug supply. The rings of carbon within the nanotubes construction can filter out many chemical, organic and bodily pollution from water. Their form might be wrapped round inside parts, shielding them throughout drug supply.

Carbon nanofibers are typically used within the manufacture of security put on, particularly biotextiles, the place they will present a number of extremely helpful qualities like liquid and stain resistance, in addition to antimicrobial properties.

Carbon nanoparticles can be utilized in mixture with heavy, non-nano supplies, like metal. When distributed all through metal, these nanoparticles can improve its power. They will in the end cut back the quantity of fabric wanted, creatinglighter weight objects with out relying solely on nanomaterials.

Nanotechnology can be used to create more practical and secure lubricants, that are helpful in a wide range of industrial purposes. On the nanoscale, supplies can act equally to ball-bearings in petroleum-based lubricants, preserving issues flowing easily, guaranteeing even distribution and limiting aggregation. They will ensure that machine parts keep lubricated, even within the face of fast adjustments in temperature or stress.

Nanotechnology can also be utilized in automotive manufacturing. Tire producers are more and more utilizing polymer nanocomposites in high-end tires to extend their sturdiness and put on resistance. As well as, nanotech might be utilized within themanufacture of improved consumer car products, like motor oil.

In electronics, nanotechnology allows the manufacture of tinyelectronics and electrical units like nanoscale transistors made out of carbon nanotubes. The extraordinarily small scale makes it attainable to print skinny and extremely versatile objects like plastic photo voltaic panels, electrical textiles and versatile gasoline sensors.

Different purposes of nanotechnology which have proven critical promise embrace nanomachines or nanites mechanical or robotic units that function on the nanoscale. Nanomachines are, for essentially the most half, future-tech and never broadly utilized in manufacturing proper now. Nonetheless, that is anticipated to vary quickly probably, inside the decade. Researchers are already beginning to be utilized in sure settings especially in medicine, where nanoscopic, self-assembling units can be utilized in ways in which normal machines cannot.

The widespread use of nanotechnology is pretty new. Lately, nonetheless, the know-how has quickly develop into extra well-liked, as new analysis and experimental design has made it clear how efficient these nanotechnologies might be.

Well-liked nanomaterials, like carbon nanotubes, are already broadly fabricated and utilized within the manufacture of a wide range of items, together with sailboat hulls, bicycle frames and spaceship parts. In electronics, design on the nanoscale is creating extremely versatile units and circuit boards. Quickly, nanoscale robots known as nanomachines or nanites could quickly revolutionize medical machine development. Nanotech and manufacturing will shortly be linked in methods that can inform future processes

Josh is Editor In Chief of Canton Sentinel Blog

He is News Journalist By Profession carrying Experience of More than 15 years.

He also supports a Charity Named as No Smoke World

Email [emailprotected]

Originally posted here:

Nanotechnology is Making Devices and Object which were Not Possible - The Canton Independent Sentinel

The global Nanotechnology in Drug Delivery market reached ~US$ xx Mn in 2019 and is anticipated grow at a CAGR of xx% over the forecast period 2019-2029. In this Nanotechnology in Drug Delivery market study, the following years are considered to predict the market footprint:

The business intelligence study of the Nanotechnology in Drug Delivery market covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). In a bid to recognize the growth prospects in the Nanotechnology in Drug Delivery market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market. Each segment of the Nanotechnology in Drug Delivery market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the Global regions.

Request Sample Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2303549&source=atm

Each market player encompassed in the Nanotechnology in Drug Delivery market study is assessed according to its market share, production footprint, current launches, agreements, ongoing R&D projects, and business tactics. In addition, the Nanotechnology in Drug Delivery market study scrutinizes the strengths, weaknesses, opportunities and threats (SWOT) analysis.

The key players covered in this studyAccess PharmaceuticalsAlkermesAquanovaCamurusCapsulution PharmaCelgene

Market segment by Type, the product can be split intoTargeted DeliveryDrug Package

Market segment by Application, split intoCancerTumorOther

Market segment by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

The study objectives of this report are:To analyze global Nanotechnology in Drug Delivery status, future forecast, growth opportunity, key market and key players.To present the Nanotechnology in Drug Delivery development in United States, Europe and China.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nanotechnology in Drug Delivery are as follows:History Year: 2014-2018Base Year: 2018Estimated Year: 2019Forecast Year 2019 to 2025For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Make An EnquiryAbout This Report @ https://www.marketresearchhub.com/enquiry.php?type=E&repid=2303549&source=atm

What insights readers can gather from the Nanotechnology in Drug Delivery market report?

The Nanotechnology in Drug Delivery market report answers the following queries:

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2303549&licType=S&source=atm

Why Choose Nanotechnology in Drug Delivery Market Report?

For More Information Kindly Contact:

marketresearchhub.com

Mr. Nachiket Ghumare,

90 State Street,

Albany NY,

United States 12207

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [emailprotected]

Read more here:

Nanotechnology in Drug Delivery Market : Drivers, Restraints, Opportunities, and Threats (2019-2025) - Packaging News 24

Dr. Thomas Mensah, a nanotechnology expert and Ghanas technology icon, is a pioneer in fiber optics manufacturing and communications systems.

He has contributed immensely to the development offiber opticsandnanotechnology. Fiber-optic communication is the use of light pulses to transmit data through cables from one place to another.

The Ghanaian-American engineers contribution to the process of making fiber optic cables has enhanced the cost-efficiency of producing those cables, paving the way for a much greater degree of fiber optics technologies at work in our world.

Mensah was born in 1950 in Kumasi, Ghana. He could read newspapers and speak French fluently and was the main contact person between his fathers business and french clients. He also won different levels of the National French Contest (Le Grand Concours) between 1968 and 1970.

Whilst in high school, Mensah excelled in science and math and went on to study chemical engineering at the University of Science and Technology, Kumasi in Ghana graduating in 1974.

He attended the Massachusetts Institute of Technology and then studied chemical engineering at the University of Science and Technology at Montpellier, France where he graduated in 1978 with a Ph.D.

Dr. Mensah moved to the United States in 1980 after taking a job as a research engineer with Air Products & Chemicals of Allentown, PA.

Three years later, he joined the engineering team of Corning Glass Works in Corning, NY. He soon discovered that the fragility of the glass fiber-optic wires which the company manufactured caused them to snap easily if the drawing and coating phases of manufacturing fiber optics were configured to produce more than two meters per second of wire.

He discovered a solution that results in the fiber optic wires greater durability and increases in production at rates of up to 20 times the previous production speed without breaking.

His groundbreaking discoveries at Corning Glass Works was the beginning of his engineering career.

In 1986, he joined Georgias AT&T Bell Laboratories, now known as Bell Labs, where he was able to utilize fiber optics to create a guidance system for missiles that incorporated a small camera that was installed within the missiles nose.

The images captured by that camera could be delivered to a pilot, giving them a technique for locking onto a target with incredible accuracy.

Reportedly,the fiber optics missile guidance systems were capable of working whiletraveling at the speed of sound and were utilized in Patriot missiles and otherguided weaponry used by the United States in the Gulf War.

InDecember 1988, Dr. Mensah was part of a team of Corning inventors who wereissued U.S. Patent No. 4792347, entitled Method for Coating Optical WaveguideFiber. The patent protects the method of using carbon dioxide as a purge gas toreduce air entrainment and bubble inclusions in the liquid coating of a glassoptical fiber.

Dr.Mensah is also one of two inventors listed on U.S. Patent No. 4636405, issuedunder the title Curing Apparatus for Coated Fiber.

He holds 14 patents with seven patents in fiber optics technologies over the course of six years.

Some of his inventions include semiconductors designed for space communications, tank gun barrel replacements and solid-state rechargeable cell phone batteries.

Dr. Mensah founded in Norcross, GA, a high tech firm called Supercond Technologies, which helped to develop advanced structural materials for American fighter aircraft.

Dr.Mensah is currently the president and director of Georgia Aerospace SystemsManufacturing, which is also focused on research and development in aerospacematerials.

Dr. Mensahs technological exploits have various recognition and award. He earned the Corning Glass Works Industrial Outstanding Contributor Award for Innovation in Fiber Optics, 1985; AT&T Bell Laboratories High-Performance Award, 1988; and the American Institute of Chemical Engineers (AIChE)s William Grimes Award for Excellence in Chemical Engineering, 2006.

He got the Kwame Nkrumah African Genius Award in Ghana in 2017, The World Nanotechnology Conference Award in Dubai, 2019, Fellow recognition at the US National Academy of Inventors, Percy Julian Award in the US, AIChE 100 amongst others.

He has also authored five books on innovation including the international textbook Nanotechnology Commercialization.

Apart from creating Silicon Valley of Ghana, Dr. Mensah is involved in several high profile infrastructure programmes in the West African country that is aimed at helping Ghana reach 90 percent of its Sustainable Development Goals.

Dr. Mensah has beendescribed as the Imhotep of Modern Times.

Read the original post:

Thomas Mensah: the pioneer of fiber optics and nanotechnology - Face2Face Africa

The arrest of Harvard ProfessorCharles Lieberfor failing to reveal his work for the Chinese is more than alarming. One of the worlds leading experts in nanotechnology, Liebercontributed toChinas Thousand Talents Program and assistedChinain its military arms race with the United States, whether knowingly or not. Americans should be concerned thatChinais pursuing military nanotechnology solutions, including linking soldiers brains directly to computers.

Since at least 2000, when President Clinton proclaimed his National Nanotechnology Initiative, US government agencies have been heavily engaged in nanotechnology research.A significant part of the work has been funded by theDefense Department, and the long-term goal is to create a new kind of warrior linking the human brain to machines, to millions of sensors and to the computer cloud. If successful, the capability of the human brain would be expanded exponentially. For the warfighter, the complete integration of sensors to shooters and near-perfect situational awareness would create a formidable soldier, and if in the hands of an enemy, a highly dangerous adversary.

The American military, especially since the microelectronics revolution, has based its superiority on technology as a force multiplier, permitting the United States to field smaller but much more lethal forces.Chinais rapidly catching up with the US military, a source of deep worry in Washington.

As more and more military operations begin to rely on artificial intelligence, a field actively pursued by the Pentagon and by the Peoples Liberation Army ofChina, the line between the warrior and machines starts to blur. Connect the human brain directly to the computers and systems making critical calculations, and the character of the warfighter is forever changed, assuming it is possible.

TheDefense Departmentin 2018 published a major study called Cyborg Soldier 2050, Human/Machine fusion and the Implications for the Future of the DoD.The study proclaimed :

neural implants for brain-computer interfacing would allow for seamless interaction between individuals and secondary assets (machines). This control could be exerted upon drones, weapon systems, and other remote systems operated by an enhanced individual. The enhancement would not simply entail user control of equipment (brain to machine) but also transmission to operator (machine to brain) and human to human (command and control dynamics) to enhance situational awareness as drone, computational analytical, and human information is relayed to the operator.

While theDefense Departmentis aiming at 2050, inventor and futurologist Ray Kurzweil sees the mind-machine interface happening by 2030, where he says the 300 million or so very general pattern recognizers in the brain can be expanded by creating a synthetic neo-cortex linking the brain to the cloud and merging artificial and human intelligence together. This will be achieved by nano-scale brain implants.

Lieberand his partners were working on exactly this type of technology and received substantial funding from the Department of Defense and many of its agencies. Lieberand his colleagues were awarded a number of patents, but the most important one appears to be a 2015 patent award called Systems and Methods for [nano-scale] Injectable Devices. The idea of the 2015 patent was to inject a nano-scale matrix into the brain and creating a brain interface that could be linked to machines.

Research for this patent was funded by theDefense Departmentand the National Institutes of Health.The government has certain rights to the invention, according to the patent application.

Lieberhas been accused by the US government of concealing information about the work he was doing inChina. In 2015, Lieberwas elected as a foreign member of the Chinese Academy of Sciences.

In 2015, the same year that Lieberwas awarded a patent enabling nanotechnology implants for the human brain, Pentagon officials sounded the alarm aboutChinaworking on their own cyborg project. Then-Deputy Defense Secretary Robert Work said:Now our adversaries, quite frankly, are pursuing enhanced human operations, and it scares the crap out of us.

Cyborg technology is also being commercialized.Elon Musks company Neuralink is now entering the animal-testing phase and states that it will start experiments on humans in 2020.Lieberis one of the consulting scientists at Neuralink. Musk has invested $100 million of his money in this startup and is raising additional funds.

Whether 2050 or 2030 or in the next few years the first Cyborg Warrior may actually appear. Will it be an American Cyborg or fromChina?No one knows.

Stephen Bryen served as a deputy undersecretary of defense and as the director of the Defense Technology Security Administration. He is a senior fellow at the American Center for Democracy.

This article was previously published in the Washington Times

See the article here:

China and US salute the cyborg soldier - Asia Times

PARIS--(BUSINESS WIRE)--Regulatory News:

Curadigm, an early-stage nanotechnology company committed to improving treatment outcomes by redefining the therapeutic balance between bioavailability, toxicity, and efficacy, announced the selection of its Nanoprimer technology by the National Cancer Institutes (NCI) Nanotechnology Characterization Laboratory (NCL) for characterization, based on its potential to significantly impact treatments in multiple disease indications, including cancer.

The broad utility of the Nanoprimer technology is due to its unique nanomedicine approach to improve therapeutic action without modifying the therapeutic in any way. Rather, the Nanoprimer is administered intravenously just prior to a therapeutic, specifically and transiently occupying the liver pathways responsible for clearance. This temporarily increases the therapeutics bioavailability and subsequent accumulation in target tissue. This mechanism, targeting the universal upstream pathways involved in intravenous drug clearance, means the Nanoprimer can be used in combination with multiple classes of nanomedicines including nucleic acid and small molecule therapeutics or gene editing technologies.

Through this collaboration, the NCL, a leader in the characterization and development of Nanomedicines, will perform in-depth pre-clinical characterizations. These studies will support the Nanoprimers development, driving advancement toward filing an Investigational New Drug (IND) with the Food and Drug Administration (FDA) and future clinical development. This work will also support ongoing and future collaborations combining the Nanoprimer with therapeutics across diverse clinical indications.

Curadigm is a 2019 Nanobiotix spin-off, that aims to reshape and elevate the efficacy of intravenously administered therapeutics. The Nanoprimer technology is based on engineered, biocompatible nanoparticles that are administered just prior to the therapeutic and acts rapidly to temporarily occupy the Kupffer and liver sinusoidal endothelial (LSEC) cells. This precision-based approach leads to enhanced systemic bioavailability for increased therapeutic action.

The NCL was established to study the use of nanoparticles and nanomedicines to advance cancer research and to accelerate the development of promising and safe nanotechnology-based cancer therapeutics. The program provides pre-clinical testing and services on a competitive acceptance basis to companies, such as Curadigm, and is working in concert with other US agencies such as the FDA to accelerate the use of nanomedicines from early-stage development to clinical applications.

The selection of our nanoprimer by the NCL is a major step for Curadigm, said Matthieu Germain, CEO of Curadigm. The standardized cascade assay developed by the NCL is a great opportunity to accelerate the development of the Nanoprimer by providing additional data about its physico-chemical properties, safety and mechanism of action that will facilitate regulatory review. The results generated through this collaboration will also be instrumental in supporting our discussions with partners to develop their therapeutics with the Nanoprimer.

About Curadigm

Curadigm, a Nanobiotix Corp spin-off, is an early-stage nanotechnology company dedicated to improving outcomes for patients by shifting the therapeutic delivery paradigm. Curadigms Nanoprimer technology increases drug bioavailability while decreasing unintended off-target effects, specifically liver & spleen toxicities. The platform can be used with most intravenous (IV) therapeutics across multiple drug classes. Curadigm is dedicated to advancing therapeutic development based on our deep understanding of how drugs interact with the body, to impact both known and novel drugs across multiple clinical indications.

For more information about Curadigm visit http://www.curadigm.com

Read more here:

Curadigm announces the selection of its Nanoprimer technology by the National Cancer Institute for a characterization & development collaboration...

Mark Jennings-Bates -Mar 13, 2020 / 6:00 am | Story:279331

Photo: hidenanalytical.com

Can nanotechnology save the world?

I believe it can and goodness knows we need some solution for what is going on whether it is:

We likely only have ourselves to blame for the challenges we are experiencing.

While the world struggles to contain the ripples from theCovid19 outbreak, some people are hard at work in labs and R&D centres around trying to find new world solutions.

It turns out those solutions come in a very tiny form and the potential for nano particles is, lets say, explored, but not implemented.

To give you an idea how small a nano particle typically is, a piece of writing or copy paper is approximately 0.05mm thick.

By comparison, 1mm is equivalent to 1,000,000 nano metres and a nano particle ranges between 1nm and 100nm. I hope you see the point, but you wont ever see a nano particle with the naked eye.

But why is something so small able to change the future of the world?

Turns out there is a lot of answers from a short question so over the next few weeks, I want to explore a burgeoning industry and talk about why nanotechnology can in fact save the world.

When you take a deep dive in to the subject, you will see that nano particles have been around for a long time, and secondly that development is advancing at a rapid rate with our knowledge of what they can be used for increasing exponentially.

Literally, we can find examples of nano particles being used very successfully in areas like road construction through to anti bacterial and anti viral applications in the medical industry.

How? Well lets start getting in to it a little more than next week.

COMMENTS WELCOME

Comments are pre-moderated to ensure they meet our guidelines. Approval times will vary. Keep it civil, and stay on topic. If you see an inappropriate comment, please use the flag feature. Comments are the opinions of the comment writer, not of Castanet. Comments remain open for one day after a story is published and are closed on weekends. Visit Castanets Forums to start or join a discussion about this story.

View post:

What can save the world? - It's All About . . . - Castanet.net

Building a structure out of toothpicks and glue takes creativity, patience and careful planning. But imagine trying to build a similar structure which height is the thickness of a piece of paper. The beams and supports, a 50th the thickness. Sounds impossible, right?

Although he cant see them with his naked eye, nanoscientist and Penticton native Nigel Clarke has been building these microscopic structure, as well as other creations, for years. For nanoscientists, thinking small in a big way is key.

Based out of Mountain View, California, Clarke works to explore new product ideas with Samsungs Thing Tank Team. His day-to-day is spent brainstorming and building new creations; from new TV displays to virtual reality, and even robot arms that cook in your kitchen.

Born and raised in Penticton, the now 27-year-old Senior Research Engineer is working to develop game-changing technology which could affect many things.

[Story continues below]

[Nanoscientist and research engineer, Nigel Clarke. Supplied]

I always liked inventing things, so I wanted to be on the bleeding edge of something, said Clarke. So when I first about nanotechnology, I was immediately attracted to it. Because it seemed like such a new field, there were so many opportunities to create new things.

After graduating from Penticton Secondary School in 2010 and the University of Waterloo for Nanotechnology Engineering in 2015, Clarke went on to receive his masters in Mechanical Engineering and Design Methodology from Stanford University in 2018. His masters was based on the most efficient way of testing and learning from products in order to figure out what should be produced.

Throughout his education he explored nanofabrication and the creation of objects so small, their structure cannot be fully appreciated with light-based microscopes.

By designing these microscopic structures, scientists can observe how certain materials behave. This allows them to create structures with unique properties, not normally seen in larger materials.

Clarke has previously worked with a group, led by California Institute of Technology professor Julia Greer, to develop this technology and turn it into something practical.

In addition to these microscopic structures, Clarke has also researched how light behaves differently at the nanoscale, which helped in the development health sensors. He also worked on the development of thin flexible electronics, used in contact lenses.

Imagine shining light through a microscope; at a certain point the ray of light is so concentrated that it has the ability to burn. At the very centre of this hourglass shape, the light is the brightest.

To start the creation of these microscopic structures, Clarke covers a surface with a light-sensitive material, Photoresist, which reacts when it comes into contact with light. When exposed to light, the Photoresist then changes from appearing like a liquid, to appearing like a solid. In other words areas that are exposed to the bright light crosslink and become a hard material, eventually forming a structure.

By moving lasers around in 3D space, they can draw microscopic structures one line at a time out of thin air.

The main thing this group was trying to do was look at these unique properties that you only get at the nano scale, pretty much a strength improvement in this normally brittle material and say; are there ways that we can bring that type of property to larger materials that we use every day, said Clarke.

In future, this could result in the creation of extremely strong structures which are also very lightweight. One use already implemented is the creation of artificial bone.

To see Clarkes photos up close, visit the St. Germain caf downtown Penticton where they are currently on display. He credited his mother for allowing him to view his photographs as art, and showcase them to the world.

READ MORE: Morning Start: Did you know there is a liquid you can breathe like air?

@PentictonNews editor@pentictonwesternnews.comLike us on Facebook and follow us on Twitter.

Lake Country Calendar

See original here:

Okanagan-born nanoscientist thinking small in a big way - BCLocalNews

DUBLIN, March 2, 2020 /PRNewswire/ -- The "Global Nanotechnology Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering.

Nanotechnology is a rapidly growing technology with potential applications in many sectors of the global economy, namely healthcare, cosmetics, energy, and agriculture among others. The technology is revolutionizing every industry, while tremendously attracting worldwide attention.

Owing to its wide range of uses, the global nanotechnology market is expected to grow at a CAGR of around 17% during the forecasted period of 2018-2024. Thus, there lies a great opportunity for industry participants to tap the fast-growing market, which would garner huge revenue on the back of the commercialization of the technology.

In the latest research study, analysts have conducted a segmented research on the nanotechnology industry, and have interpreted the key market trends & developments that clearly highlight the areas offering promising possibilities for industries to boost their growth.

In 2017, the global nanotechnology market has shown impressive growth owing to factors, like an increase in government and private sector funding for R&D, partnerships & strategic alliances between countries, and increased in demand for smaller and more powerful devices at affordable prices. At present, the healthcare industry is one of the largest sectors where nanotechnology has made major breakthroughs with its application for the diagnosis and treatment of chronic diseases like cancer, heart ailments, etc. Further, significant developments are also being done in other sectors like electronics, agriculture, and energy.

In this report, the analysts have studied the current nanotechnology market on segment basis (by application, by component and by region), so as to provide an insight on the current market scenario as well as forecasts of the aforementioned segments till 2024. The report provides an in-depth analysis of all the major segments, taking into account the major developments taking place at the global level in the respective segments that will further boost the growth of the nanotechnology market.

Further, the application section covers the use of nanotechnology in electronics, energy, cosmetics, medical, defence, and food and agriculture sectors; while the component section covers the segregation of nanotechnology market into nanomaterials, nanotools, and nanodevices.

Additionally, the report covers the country-level analysis of 13 major countries like the US, France, UK, Germany, and Russia among others in terms of R&D, nanotechnology patent analysis, funding, and regulations, to provide an in-depth understanding about the investments and recent research & developments done in the field of nanotechnology.

The report covers the profiles of key players like Altair, Nanophase Tech, Nanosys, etc. with the key financials, strength & weakness analyses, and recent activities, providing a comprehensive outlook of the global nanotechnology industry. Overall, the report provides all the pre-requisite information for clients looking to venture in this industry, and facilitate them to formulate schemes while going for an investment/partnership in the industry.

Story continues

Key Topics Covered

1. Analyst View

2. Research Methodology

3. Nanotechnology - An Introduction

4. Key Market Trends and Developments4.1 Nanotech Tools Open Market for more Miniature Electronics4.2 Nanotechnology Accelerating Healthcare and Medical Device Industry4.3 International Collaborations for Nanotechnology Research4.4 Nanotechnology Playing a Vital Role in the Growth of Energy Industry4.5 Nanotechnology Playing a Key Role in the Growth of Food & Agriculture Industry

5. Nanotechnology Market Outlook to 20245.1 By Components5.1.1 Nanomaterials5.1.2 Nanotools5.1.3 Nanodevices5.2 By Major Applications5.2.1 Electronics5.2.2 Energy5.2.3 Cosmetics5.2.4 Biomedical5.2.5 Defense5.2.6 Food and Agriculture

6. Country-Level Analysis(Funding, Research & Developments, Regulations)6.1 U.S.6.2 Brazil6.3 Germany6.4 France6.5 U.K.6.6 Ireland6.7 Russia6.8 Japan6.9 South Korea6.10 Taiwan6.11 China6.12 India6.13 Australia

7. Patents Analysis

8. Competitive Landscape8.1 Altair Nanotechnologies Inc.8.2 Nanophase Technologies Corporation8.3 Nanosys, Inc.8.4 Unidym, Inc. (subsidiary of WisePower Co.)8.5 Ablynx8.6 Zyvex Corporation8.7 Acusphere, Inc.8.8 Chasm Technologies, Inc.8.9 PEN, Inc.8.10 Bruker Nano GmbH8.11 Advanced Diamond Technologies, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/g2y67j

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/nanotechnology-industry-insights--outlook-2020-2024-by-component-application-and-region-301014543.html

SOURCE Research and Markets

More:

Nanotechnology Industry Insights & Outlook, 2020-2024 by Component, Application and Region - Yahoo Finance

There is no doubt nanotechnology constitutes one of the most relevant technology disruptions during the past and present century. The physicochemical properties of nanomaterials have been leveraged in a broad spectrum of industries and sectors. Nevertheless, the same properties demand critical care from an occupational point of view.

In a previous article, the risks associated with the typical exposure to nanomaterials in the workplace were highlighted (Van Cauwenberghe, 2019) as strongly related to a wide range of both acute and chronic effects, including inflammation, asthma, cystic fibrosis, lung diseases and cancer, especially emphasising on neurotoxicity, due to inhaled nanoparticles penetrating inside the olfactory mucosa that translocate in the central nervous system.

This article intends to open up the discussion about the role and interaction of researchers and manufacturers, as well as policymakers and insurers to manage risks associated with the use of nanotechnology.

An investigation carried out by the Section of Occupational Medicine, Department of Public Health, University of Naples Federico II, along with the Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers Compensation Authority (INAIL), deeply details the occupational health concerns and safety risks potentially derived from nanoscale biomedical applications (Leso et al., 2019). In particular, this study focuses on the risks associated with nanotherapeutics and drug delivery systems, medical imaging agents and tissue engineering. Nanocrystals, drug-free nanoparticles, inorganic and metallic nanoparticles, polymeric drugs, liposomes and micelles are mentioned.

According to the investigators, laboratory workers involved in the research, synthesis, preparation, delivery and management of biomedical nanotech-based products from the lab to clinical pharmacies are all exposed to nanomaterials related occupational health risks. From the researchers to patients, physicians, pharmacists, dentists, nurses, as well as personnel involved in shipping, receiving and maintenance may also come into contact with nanomaterials while handling items.

Furthermore, disposal of excreta from patients receiving nanomedicines, cleaning equipment, use and spill of nano-enabled contrast agents, need to be taken into consideration in the development of safety headlines intending to address risk management. The effects of the toxicity of nanomaterials on the human body and surrounding biosystems depend on the nature, particle size, shape, substituents, and coatings of nanoparticles (Nasrollahzadeh and Sajadi, 2019).

The Worcester Polytechnic Institute performed an in-depth assessment regarding the perceptions that advanced technology companies and researchers have regarding emerging technologies, with a focus on nanotechnology, with regard to risk management for TEMAS AG, a Swiss management consultancy focused on advanced technology. Part of the study consisted of interviews with advanced technology companies and nanotechnology researchers, to really catch the essence of the work with nanotechnology. According to the investigators, as a modern technology, nanotechnology has risks. The science dilemma appears in the awareness of these technologies cannot improve without assuming a certain level of risk (Macorri et al., 1019).

In the near future, for instance, breakthrough transformations may occur as a result of molecular production, an advanced form of nanotechnology. Another of the key aspects identified in the study was the lack of involvement from insurance companies inadequately covering nanotechnologies and other emerging risks. The balance between the benefit of a certain nanotech-based product and the level of risk involved needs to be considered in the equation. On that note, policymakers play a fundamental role in guaranteeing an optimistic future for nanotechnology by maximising benefits and minimising risks (Kosal, 2019).

Decisions on the adoption of advanced technological innovation are seriously difficult for manufacturers. This aspect becomes more essential for small and medium enterprises (SMEs). These companies significantly drive product development; however, they have limited resources. Sometimes, these limitations make challenging the path to address safety issues. It is important to highlight the role of decision analytic methods applied to regulatory issues in the nanotechnology sector. Although prospective, these tools are poorly developed until now. Researchers emphasise in the value of information (VoI) as a decision analytic tool to facilitate decision-making procedures in nanotechnology manufacturing (Zabeo et al., 2019).

As the production of nanomaterials increases worldwide, safety issues related to toxicity and health risks of nanotechnology have gained increased attention from toxicologists and regulatory scientists. The relevancy of this awareness has foundation on that fact that nanomaterials are connected to all aspects of human life. Next steps will demand a profound commitment of researchers, manufacturers, policymakers and health insurers to guarantee successful management of risks associated with the use of nanotechnology.

You might like to read a previous article form Cecilia Van Cauwenberghe, that focuses on nanomaterials, looking at the challenges and opportunities around the laser ablation in liquid environment (LALE) technique. In this article, we find out that LALE is a straightforward technique to build a broad spectrum of nanostructured materials or nanomaterials and that it constitutes the most efficient and straightforward technique to create nanostructured materials in a safe and effective manner for both human health and the environment.

You can learn more on the LALE technique in another insightful article from Cecilia Van Cauwenberghe. Here, we learn that potential applications of the LALE technique include antimicrobial coatings to prevent infections and that pulsed laser ablation in the LALE technique has exhibited a variety of advantages over conventional chemical synthesis methods.

Further readingKosal, M.E., 2019. The threats from nanotechnology. Bulletin of the Atomic Scientists, 75(6), pp.290-294.Leso, V., Fontana, L. and Iavicoli, I., 2019. Biomedical nanotechnology: Occupational views. Nano Today, 24, pp.10-14.Li, X., 2019. Emerging technologies, emerging knowledge: intentions to seek and share information on social media about the risks and bene- fits of nanotechnology (Doctoral dissertation).Macorri, E., MacInnis, L.J., Connor Recio, M.A. and Lepage, T.J., 2019. Nanotechnology: Perceived Risks and Risk Management. Nasrollahzadeh, M. and Sajadi, S.M., 2019. Risks of Nanotechnology to Human Life. In Interface Science and Technology (Vol. 28, pp. 323-336). Elsevier.Van Cauwenberghe, 2019. Open Access Government October 2019. Zabeo, A., Keisler, J.M., Hristozov, D., Marcomini, A. and Linkov, I., 2019. Value of information analysis for assessing risks and benefits of nan- otechnology innovation. Environmental Sciences Europe, 31(1), p.11.

Editor's Recommended Articles

See the original post here:

Nanotechnology: Work-related aspects - Open Access Government